Babraham Distinguished Lecture - Elucidating new ways to target downstream of KRAS mutation in colorectal cancer : metabolic and microenvironment targets

Add to your list(s) Download to your calendar using vCal

• Prof. Owen Sansom; Director of The Beatson Institute for Cancer Research, University of Glasgow
• Wednesday 24 April 2019, 14:00-15:00
• Babraham - The Cambridge Building - Petersfield Lecture Theatre.

If you have a question about this talk, please contact Bobbie Claxton.

If you would like to attend this lecture, please contact us to arrange site access *This lecture will conclude with networking drinks*

My laboratory has spent a number of years understanding the key consequences of loss of the APC (Adenomatous Polyposis Coli) gene in vivo. Loss of the gene is common to most colorectal cancers (80%) and is thought to initiate CRC . We have found many of our ways to target APC deficient cells stop working when there is additional mutation of KRAS . KRAS is mutated in 40% of CRC and currently acts a negative indicator for EGFR based therapies. In my talk, I will discuss the work we have down investigating the key mechanistic pathways activated in cells that lose both APC and mutate KRAS . I will focus on our work on metabolism and particularly the SLC7A5 (LAT1 transporter) that link metabolism into protein synthesis.

Finally I will discuss our work developing metastatic models of CRC and key determinants of KRAS mutant CRC . Once again these studies have identified a key role for neutrophils in these models.

This talk is part of the Babraham Seminar series.

This talk is included in these lists:

• Babraham - The Cambridge Building - Petersfield Lecture Theatre
• Babraham Seminar
• Graduate-Seminars
• se393's list

Note that ex-directory lists are not shown.